Rivus Pharmaceuticals has dosed the first patients in the AMPLIFY Phase II clinical trial evaluating HU6, an investigational ...

The FDA’s recently unveiled plausible mechanism framework may have been forged with i | The FDA’s newly launched plausible ...

Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a ...

There are plenty of frozen foods that support heart health and can make meal-prep more convenient—you just have to know which ones to pick. These frozen foods contain vitamins and nutrients that make ...

A controlled trial examines how different protein choices influence metabolic health, offering new insight into diet and ...

Median overall survival increased by >40% in elraglusib arm compared to the control arm, with a 1-year survival rate of 44% in the elraglusib ...

Primary endpoint didn’t reach significance, but secondary endpoints showed nausea reduction with herbal supplement from ...

This randomized, double-blind, placebo-controlled, single ascending-dose study evaluated oral doses of the botanical kratom ...

Kiora Pharmaceuticals (NASDAQ: KPRX) today announced the publication of the results from its Phase 1 ABACUS-1 study of KIO-301 in Nature Medicine. The publication adds clinical detail to a program ...

Adolescent major depressive disorder represents a personal and public health challenge. Conventional drug treatments don’t ...

Trial met all primary and key secondary endpoints, including progression-free survival and overall survival Company intends to include these data ...

Residential Therapy With Navigated Transcranial Magnetic Stimulation for Combat-Related PTSD 1. In adult patients with combat-related post-traumatic stress disorder (PTSD) undergoing residential ...